||||||||||cannabidiol (CBD) / Claritas Pharma Enrollment closed, Trial completion date, Trial primary completion date: An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD) (clinicaltrials.gov) - Sep 1, 2021 P2a, N=36, Active, not recruiting, Sponsor: Kalytera Therapeutics Israel, Ltd. Recruiting --> Active, not recruiting | Trial completion date: Nov 2019 --> Dec 2022 | Trial primary completion date: Oct 2019 --> Nov 2022